IFNA1 and COVID-19: In addition to genetic variations in PRRs, anti-IFN neutralizing autoantibodies that target IFN-α/ω have been associated with reduced expression of IFN-stimulated genes (ISGs) and life-threatening or fatal cases of COVID-19 [20,21,22,23].